Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bös M[au]:

Comprehensive genomic profiles of small cell lung cancer. George J et al. Nature. (2015)

CD74-NRG1 fusions in lung adenocarcinoma. Fernandez-Cuesta L et al. Cancer Discov. (2014)

Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors. Ortiz-Cuaran S et al. Clin Cancer Res. (2016)

Search results

Items: 1 to 50 of 446

1.

The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer.

Claessens AKM, Timman R, Busschbach JJ, Bouma JM, Rademaker-Lakhai JM, Erdkamp FLG, Tjan-Heijnen VCG, Bos MEMM; Dutch Breast Cancer Research Group (BOOG).

Breast Cancer Res Treat. 2019 Nov 28. doi: 10.1007/s10549-019-05495-3. [Epub ahead of print]

PMID:
31782032
2.

Coagulopathy after hemorrhagic traumatic brain injury, an observational study of the incidence and prognosis.

van Gent JAN, van Essen TA, Bos MHA, Cannegieter SC, van Dijck JTJM, Peul WC.

Acta Neurochir (Wien). 2019 Nov 18. doi: 10.1007/s00701-019-04111-z. [Epub ahead of print]

PMID:
31741112
3.

Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer.

Heeg E, Marang-van de Mheen PJ, Van Maaren MC, Schreuder K, Tollenaar RAEM, Siesling S, Bos MEMM, Vrancken Peeters MTFD.

Int J Cancer. 2019 Nov 12. doi: 10.1002/ijc.32788. [Epub ahead of print]

PMID:
31721193
4.

Multi-ancestry sleep-by-SNP interaction analysis in 126,926 individuals reveals lipid loci stratified by sleep duration.

Noordam R, Bos MM, Wang H, Winkler TW, Bentley AR, Kilpeläinen TO, de Vries PS, Sung YJ, Schwander K, Cade BE, Manning A, Aschard H, Brown MR, Chen H, Franceschini N, Musani SK, Richard M, Vojinovic D, Aslibekyan S, Bartz TM, de Las Fuentes L, Feitosa M, Horimoto AR, Ilkov M, Kho M, Kraja A, Li C, Lim E, Liu Y, Mook-Kanamori DO, Rankinen T, Tajuddin SM, van der Spek A, Wang Z, Marten J, Laville V, Alver M, Evangelou E, Graff ME, He M, Kühnel B, Lyytikäinen LP, Marques-Vidal P, Nolte IM, Palmer ND, Rauramaa R, Shu XO, Snieder H, Weiss S, Wen W, Yanek LR, Adolfo C, Ballantyne C, Bielak L, Biermasz NR, Boerwinkle E, Dimou N, Eiriksdottir G, Gao C, Gharib SA, Gottlieb DJ, Haba-Rubio J, Harris TB, Heikkinen S, Heinzer R, Hixson JE, Homuth G, Ikram MA, Komulainen P, Krieger JE, Lee J, Liu J, Lohman KK, Luik AI, Mägi R, Martin LW, Meitinger T, Metspalu A, Milaneschi Y, Nalls MA, O'Connell J, Peters A, Peyser P, Raitakari OT, Reiner AP, Rensen PCN, Rice TK, Rich SS, Roenneberg T, Rotter JI, Schreiner PJ, Shikany J, Sidney SS, Sims M, Sitlani CM, Sofer T, Strauch K, Swertz MA, Taylor KD, Uitterlinden AG, van Duijn CM, Völzke H, Waldenberger M, Wallance RB, van Dijk KW, Yu C, Zonderman AB, Becker DM, Elliott P, Esko T, Gieger C, Grabe HJ, Lakka TA, Lehtimäki T, North KE, Penninx BWJH, Vollenweider P, Wagenknecht LE, Wu T, Xiang YB, Zheng W, Arnett DK, Bouchard C, Evans MK, Gudnason V, Kardia S, Kelly TN, Kritchevsky SB, Loos RJF, Pereira AC, Province M, Psaty BM, Rotimi C, Zhu X, Amin N, Cupples LA, Fornage M, Fox EF, Guo X, Gauderman WJ, Rice K, Kooperberg C, Munroe PB, Liu CT, Morrison AC, Rao DC, van Heemst D, Redline S.

Nat Commun. 2019 Nov 12;10(1):5121. doi: 10.1038/s41467-019-12958-0.

5.

Effect of Anesthesia on Microelectrode Recordings during Deep Brain Stimulation Surgery in Tourette Syndrome Patients.

Bos MJ, Alzate Sanchez AM, Smeets AYJM, Bancone R, Ackermans L, Absalom AR, Buhre WF, Roberts MJ, Janssen MLF.

Stereotact Funct Neurosurg. 2019 Nov 8:1-7. doi: 10.1159/000503691. [Epub ahead of print]

6.

Enhanced functional recombinant factor IX production by human embryonic kidney cells engineered to overexpress VKORC1.

Pakdaman SF, Vatandoost J, Bos MHA.

Biotechnol Prog. 2019 Nov 1:e2938. doi: 10.1002/btpr.2938. [Epub ahead of print]

PMID:
31677255
7.

Improved activity and expression of recombinant human factor IX by propeptide engineering.

Vatandoost J, Bos MHA.

Daru. 2019 Dec;27(2):653-660. doi: 10.1007/s40199-019-00299-8. Epub 2019 Oct 21.

8.

Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A single-centre randomized controlled trial.

Jongen PJ, van Mastrigt GA, Heerings M, Visser LH, Ruimschotel RP, Hussaarts A, Duyverman L, Valkenburg-Vissers J, Cornelissen J, Bos M, van Droffelaar M, Donders R.

PLoS One. 2019 Oct 10;14(10):e0223482. doi: 10.1371/journal.pone.0223482. eCollection 2019.

9.

Emotional functioning and the development of internalizing and externalizing problems in young boys with and without autism spectrum disorder.

Li B, Bos MG, Stockmann L, Rieffe C.

Autism. 2019 Sep 24:1362361319874644. doi: 10.1177/1362361319874644. [Epub ahead of print]

PMID:
31549858
10.

Clinical implications of differential antivenom efficacy in neutralising coagulotoxicity produced by venoms from species within the arboreal viperid snake genus Trimeresurus.

Debono J, Bos MHA, Frank N, Fry B.

Toxicol Lett. 2019 Nov;316:35-48. doi: 10.1016/j.toxlet.2019.09.003. Epub 2019 Sep 8.

PMID:
31509773
11.

Assessing the effectiveness of perioperative s-ketamine on new-onset headache after resective epilepsy surgery (ESPAIN-trial): protocol for a randomised, double-blind, placebo-controlled trial.

Sloekers JCT, Bos M, Hoogland G, Bastiaenen C, van Kuijk S, Theunissen M, Rijkers K, Dings J, Colon A, Rouhl RPW, Schijns OEMG.

BMJ Open. 2019 Sep 3;9(8):e030580. doi: 10.1136/bmjopen-2019-030580.

12.

Familial occurrence of mitral regurgitation in patients with mitral valve prolapse undergoing mitral valve surgery.

Hiemstra YL, Wijngaarden ALV, Bos MW, Schalij MJ, Klautz RJ, Bax JJ, Delgado V, Barge-Schaapveld DQ, Marsan NA.

Eur J Prev Cardiol. 2019 Sep 2:2047487319874148. doi: 10.1177/2047487319874148. [Epub ahead of print]

PMID:
31475862
13.

Dutch guideline for preventing nosocomial transmission of highly-resistant micro-organisms (HRMO) in long-term care facilities (LTCFs).

Eikelenboom-Boskamp A, Haaijman J, Bos M, Saris K, Poot E, Voss A; expert group ‘Long-term care facilities’ of the former Dutch Working Party on infection control.

Antimicrob Resist Infect Control. 2019 Aug 27;8:146. doi: 10.1186/s13756-019-0586-3. eCollection 2019.

14.

The Vascular Endothelial Growth Factor Inhibitor Soluble FLT-1 Ameliorates Atopic Dermatitis in APOC1 Transgenic Mice.

van Aanhold CCL, Bus P, Zandbergen M, Bos M, Berbée JFP, Quint KD, Bruijn JA, Baelde HJ.

J Invest Dermatol. 2019 Aug 16. pii: S0022-202X(19)32697-1. doi: 10.1016/j.jid.2019.07.700. [Epub ahead of print] No abstract available.

PMID:
31425708
15.

Age and Gender Effects in Sensitivity to Social Rewards in Adolescents and Young Adults.

Altikulaç S, Bos MGN, Foulkes L, Crone EA, van Hoorn J.

Front Behav Neurosci. 2019 Jul 29;13:171. doi: 10.3389/fnbeh.2019.00171. eCollection 2019.

16.

Relating the number of human leucocytes antigen mismatches to pregnancy complications in oocyte donation pregnancies: study protocol for a prospective multicentre cohort study (DONOR study).

van Bentem K, Lashley E, Bos M, Eikmans M, Heidt S, Claas F, le Cessie S, van der Hoorn ML.

BMJ Open. 2019 Jul 24;9(7):e027469. doi: 10.1136/bmjopen-2018-027469.

17.

Can disparity in access to living-donor kidney transplants between ethnic groups be mitigated?

Bos M.

Transpl Int. 2019 Oct;32(10):1028-1029. doi: 10.1111/tri.13480. No abstract available.

PMID:
31318995
18.

Clinical implications of coagulotoxic variations in Mamushi (Viperidae: Gloydius) snake venoms.

Debono J, Bos MHA, Do MS, Fry BG.

Comp Biochem Physiol C Toxicol Pharmacol. 2019 Nov;225:108567. doi: 10.1016/j.cbpc.2019.108567. Epub 2019 Jul 12.

PMID:
31306806
19.

Motor neuron disease with malignancy: Clinical and pathophysiological insights.

Higashihara M, Menon P, Geevasinga N, Van den Bos MAJ, Kiernan MC, Vucic S.

Clin Neurophysiol. 2019 Sep;130(9):1557-1561. doi: 10.1016/j.clinph.2019.05.026. Epub 2019 Jun 22.

PMID:
31301633
20.

Moderate positive predictive value of a multiplex real-time PCR on whole blood for pathogen detection in critically ill patients with sepsis.

van de Groep K, Bos MP, Varkila MRJ, Savelkoul PHM, Ong DSY, Derde LPG, Juffermans NP, van der Poll T, Bonten MJM, Cremer OL; MARS consortium.

Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1829-1836. doi: 10.1007/s10096-019-03616-w. Epub 2019 Jun 26.

21.

BMI-associated gene variants in FTO and cardiometabolic and brain disease: obesity or pleiotropy?

Ganeff IMM, Bos MM, van Heemst D, Noordam R.

Physiol Genomics. 2019 Aug 1;51(8):311-322. doi: 10.1152/physiolgenomics.00040.2019. Epub 2019 Jun 14.

PMID:
31199196
22.

Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques.

van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S.

Int J Mol Sci. 2019 Jun 10;20(11). pii: E2818. doi: 10.3390/ijms20112818. Review.

23.

Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding.

Schreuder M, Reitsma PH, Bos MHA.

J Thromb Haemost. 2019 Aug;17(8):1229-1239. doi: 10.1111/jth.14487. Epub 2019 Jun 17. Review.

24.

The Association between Habitual Sleep Duration and Sleep Quality with Glycemic Traits: Assessment by Cross-Sectional and Mendelian Randomization Analyses.

Bos MM, van Heemst D, Donga E, de Mutsert R, Rosendaal FR, Blauw GJ, Rensen PCN, Biermasz NR, Noordam R.

J Clin Med. 2019 May 15;8(5). pii: E682. doi: 10.3390/jcm8050682.

25.

An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability.

van Mastrigt GA, Evers SM, Heerings M, Visser LH, Ruimschotel RP, Hussaarts A, Duyverman L, Valkenburg-Vissers J, Cornelissen J, Bos M, van Droffelaar M, Jongen PJ.

J Med Econ. 2019 Oct;22(10):967-980. doi: 10.1080/13696998.2019.1609300. Epub 2019 May 14.

PMID:
31084442
26.

Snakebites and microvesicles: Popping bubbles.

Bos MHA, Versteeg HH.

Res Pract Thromb Haemost. 2019 Jan 15;3(2):156-157. doi: 10.1002/rth2.12180. eCollection 2019 Apr. No abstract available.

27.

Giant internal jugular vein.

Bos MJ, Van Zundert AA.

Indian J Anaesth. 2019 Apr;63(4):329-330. doi: 10.4103/ija.IJA_59_19. No abstract available.

28.

Basal but divergent: Clinical implications of differential coagulotoxicity in a clade of Asian vipers.

Debono J, Bos MHA, Coimbra F, Ge L, Frank N, Kwok HF, Fry BG.

Toxicol In Vitro. 2019 Aug;58:195-206. doi: 10.1016/j.tiv.2019.03.038. Epub 2019 Mar 28.

PMID:
30930232
29.

Coagulotoxic effects by brown snake (Pseudonaja) and taipan (Oxyuranus) venoms, and the efficacy of a new antivenom.

Zdenek CN, Hay C, Arbuckle K, Jackson TNW, Bos MHA, Op den Brouw B, Debono J, Allen L, Dunstan N, Morley T, Herrera M, Gutiérrez JM, Williams DJ, Fry BG.

Toxicol In Vitro. 2019 Aug;58:97-109. doi: 10.1016/j.tiv.2019.03.031. Epub 2019 Mar 22.

PMID:
30910521
30.

Reactive Species Interactome Alterations in Oocyte Donation Pregnancies in the Absence and Presence of Pre-Eclampsia.

Bos M, Schoots MH, Fernandez BO, Mikus-Lelinska M, Lau LC, Eikmans M, van Goor H, Gordijn SJ, Pasch A, Feelisch M, van der Hoorn MP.

Int J Mol Sci. 2019 Mar 6;20(5). pii: E1150. doi: 10.3390/ijms20051150.

31.

Two-Year Follow-Up of a Multi-centre Randomized Controlled Trial to Study Effectiveness of a Hospital-Based Work Support Intervention for Cancer Patients.

Tamminga SJ, Verbeek JHAM, Bos MMEM, Fons G, Kitzen JJEM, Plaisier PW, Frings-Dresen MHW, de Boer AGEM.

J Occup Rehabil. 2019 Dec;29(4):701-710. doi: 10.1007/s10926-019-09831-8.

32.

Sex Effects on Development of Brain Structure and Executive Functions: Greater Variance than Mean Effects.

Wierenga LM, Bos MGN, van Rossenberg F, Crone EA.

J Cogn Neurosci. 2019 May;31(5):730-753. doi: 10.1162/jocn_a_01375. Epub 2019 Feb 6.

PMID:
30726177
33.

Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS.

Geevasinga N, Howells J, Menon P, van den Bos M, Shibuya K, Matamala JM, Park SB, Byth K, Kiernan MC, Vucic S.

Neurology. 2019 Feb 5;92(6):e536-e547. doi: 10.1212/WNL.0000000000006876. Epub 2019 Jan 11.

PMID:
30709964
34.

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.

Orsi FA, Biedermann JS, Kruip MJHA, van der Meer FJ, Rosendaal FR, van Hylckama Vlieg A, Bos MHA, Leebeek FWG, Cannegieter SC, Lijfering WM.

J Thromb Haemost. 2019 Feb;17(2):319-328. doi: 10.1111/jth.14364. Epub 2019 Feb 3.

35.

Utility of threshold tracking transcranial magnetic stimulation in ALS.

Vucic S, van den Bos M, Menon P, Howells J, Dharmadasa T, Kiernan MC.

Clin Neurophysiol Pract. 2018 Nov 17;3:164-172. doi: 10.1016/j.cnp.2018.10.002. eCollection 2018. Review.

36.

Habu coagulotoxicity: Clinical implications of the functional diversification of Protobothrops snake venoms upon blood clotting factors.

Debono J, Bos MHA, Nouwens A, Ge L, Frank N, Kwok HF, Fry BG.

Toxicol In Vitro. 2019 Mar;55:62-74. doi: 10.1016/j.tiv.2018.11.008. Epub 2018 Nov 22.

PMID:
30471431
37.

High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.

Rietveld IM, Lijfering WM, le Cessie S, Bos MHA, Rosendaal FR, Reitsma PH, Cannegieter SC.

J Thromb Haemost. 2019 Jan;17(1):99-109. doi: 10.1111/jth.14343. Epub 2018 Dec 18.

PMID:
30471183
38.

Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation.

Rietveld IM, Schreuder M, Reitsma PH, Bos MHA.

Thromb Res. 2018 Dec;172:104-109. doi: 10.1016/j.thromres.2018.10.020. Epub 2018 Oct 25.

PMID:
30408635
39.

Associations of sleep duration and quality with serum and hepatic lipids: The Netherlands Epidemiology of Obesity Study.

Bos MM, Noordam R, van den Berg R, de Mutsert R, Rosendaal FR, Blauw GJ, Rensen PCN, Biermasz NR, van Heemst D.

J Sleep Res. 2019 Aug;28(4):e12776. doi: 10.1111/jsr.12776. Epub 2018 Oct 15.

PMID:
30324729
40.

The ApoE ε4 Isoform: Can the Risk of Diseases be Reduced by Environmental Factors?

Bos MM, Noordam R, Blauw GJ, Slagboom PE, Rensen PCN, van Heemst D.

J Gerontol A Biol Sci Med Sci. 2019 Jan 1;74(1):99-107. doi: 10.1093/gerona/gly226. Review.

PMID:
30321297
41.

The rippling dynamics of valenced messages in naturalistic youth chat.

Frey S, Donnay K, Helbing D, Sumner RW, Bos MW.

Behav Res Methods. 2019 Aug;51(4):1737-1753. doi: 10.3758/s13428-018-1140-6.

PMID:
30306408
42.

Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS.

Van den Bos MAJ, Higashihara M, Geevasinga N, Menon P, Kiernan MC, Vucic S.

Neurology. 2018 Oct 30;91(18):e1669-e1676. doi: 10.1212/WNL.0000000000006438. Epub 2018 Oct 3.

PMID:
30282772
43.

Evaluating Regeneration Options of Solid Amine Sorbent for CO2 Removal.

Bos MJ, Kroeze V, Sutanto S, Brilman DWF.

Ind Eng Chem Res. 2018 Aug 15;57(32):11141-11153. doi: 10.1021/acs.iecr.8b00768. Epub 2018 Aug 1.

44.

Longitudinal structural brain development and externalizing behavior in adolescence.

Bos MGN, Wierenga LM, Blankenstein NE, Schreuders E, Tamnes CK, Crone EA.

J Child Psychol Psychiatry. 2018 Oct;59(10):1061-1072. doi: 10.1111/jcpp.12972.

45.

Clinical Significance of Early Repolarization in Long QT Syndrome.

Sugrue A, Rohatgi RK, Bos M, Vaidya VR, Asirvatham SJ, Noseworthy PA, Ackerman MJ.

JACC Clin Electrophysiol. 2018 Sep;4(9):1238-1244. doi: 10.1016/j.jacep.2018.06.007. Epub 2018 Aug 29.

46.

Reproducibility of motor unit number index and multiple point stimulation motor unit number estimation in controls.

Higashihara M, Menon P, van den Bos M, Geevasinga N, Vucic S.

Muscle Nerve. 2018 Nov;58(5):660-664. doi: 10.1002/mus.26339. Epub 2018 Oct 15.

PMID:
30194855
47.

Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04).

van Rossum AGJ, Kok M, van Werkhoven E, Opdam M, Mandjes IAM, van Leeuwen-Stok AE, van Tinteren H, Imholz ALT, Portielje JEA, Bos MMEM, van Bochove A, Wesseling J, Rutgers EJ, Linn SC, Oosterkamp HM; MATADOR Trialists' Group.

Eur J Cancer. 2018 Oct;102:40-48. doi: 10.1016/j.ejca.2018.07.013.

48.

Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG).

Claessens AKM, Bos MEMM, Lopez-Yurda M, Bouma JM, Rademaker-Lakhai JM, Honkoop AH, de Graaf H, van Druten E, van Warmerdam LJC, van der Sangen MJC, Tjan-Heijnen VCG, Erdkamp FLG; Dutch Breast Cancer Research Group (BOOG).

Breast Cancer Res Treat. 2018 Nov;172(2):413-423. doi: 10.1007/s10549-018-4906-8. Epub 2018 Aug 18.

PMID:
30121808
49.

Factor V levels and risk of venous thrombosis: The MEGA case-control study.

Rietveld IM, Bos MHA, Lijfering WM, Li-Gao R, Rosendaal FR, Reitsma PH, Cannegieter SC.

Res Pract Thromb Haemost. 2018 Apr 14;2(2):320-326. doi: 10.1002/rth2.12091. eCollection 2018 Apr.

50.

Accuracy of postvoid residual volumes after vaginal delivery: a prospective equivalence study to compare an automatic scanning device with transurethral catheterization.

Mulder FEM, van der Velde S, Pol F, Bos M, van Leeuwen JS, Dietz V, Hakvoort RA, Roovers JWR.

Int Urogynecol J. 2019 May;30(5):773-778. doi: 10.1007/s00192-018-3700-9. Epub 2018 Jun 27.

Supplemental Content

Support Center